News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
O'Loughlin Steve
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| O'Loughlin Steve (CFO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 59,066 options to buy
@ $0 |
|
| 07/16/2019 |
4
| O'Loughlin Steve (Principal Financial Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.232, valued at
$92.8k
|
|
| 12/10/2018 |
4
| O'Loughlin Steve (Principal Financial Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $0.435, valued at
$4.4k
|
|
| 07/17/2018 |
4
| O'Loughlin Steve (Principal Financial Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 265,000 options to buy
@ $0.7829, valued at
$207.5k
|
|
| 06/15/2018 |
4
| O'Loughlin Steve (Principal Financial Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Bought 12,000 shares
@ $0.5, valued at
$6k
|
|
| 03/08/2018 |
4
| O'Loughlin Steve (Principal Financial Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Acquired 10,000 shares
@ $0.5, valued at
$5k
Acquired 2,500 options to buy
@ $0.6, valued at
$1.5k
Acquired 7,500 options to buy
@ $0.7, valued at
$5.3k
|
|
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|